Aridana Sandika IM, Sastrawan MO, Arsa Wibawa NGB. Does Germline BRCA1/2 Status Modify the Effect of Neoadjuvant Pembrolizumab on Pathological Complete Response in Early-Stage Triple-Negative Breast Cancer? A Systematic Review and Meta-analysis of Treatment-Biomarker Interactions. Bioscmed [Internet]. 2026 Aug. 20 [cited 2026 Aug. 23];10(10):2896-908. Available from: https://bioscmed.com/index.php/bsm/article/view/1658